You're thinking of auditory neurons. Synapses connect hair cells and neurons, they necessarily die when hair cells do.
Yes you're right I was thinking of auditory neurons.
You're thinking of auditory neurons. Synapses connect hair cells and neurons, they necessarily die when hair cells do.
Yes you are correct. I was thinking about the typical notch (3-4 kHz) in audiograms that is so recognisable for NIHL.It seems you're just thinking about acoustic trauma causes.
I hope so too. 10 kHz - 16 kHz are quite important for music and if this can help with tinnitus it would be just amazing !
I think i'm gonna stop talking.
Have a good day
I d say its 16khz cuz thats where typical mp3 compression cuts off, but i d be happy with even 10k.I would be so happy to have those frequencies back and enjoy the music again.
Around 6000 hz I notice a reduction and slight distortion in my right ear that cuts off to a very low volume around 11,000 hz. It ruins some of my favorite music, it distorts birds chirping and crickets at night.
The ideal goal for us music lovers is to have 0 to 15,000 Hz not just the human voice range.
The ideal goal for us music lovers is to have 0 to 15,000 Hz not just the human voice range.
Than a lot of digital sound systems need revisingMaybe 22 kHz is a good spot.
Than a lot of digital sound systems need revising
I would say it has gone off topic. Maybe start a new thread to talk about this stuff?I have a feeling this is going off topic, but I'm curious as to why?
I would say it has gone off topic. Maybe start a new thread to talk about this stuff?
I think the answer to this could be nano technology, or nano medicine. For years, nano particles has been tested and developed within the research field of a variety medicine. I found an article dating back to 2011 from my country talking about how they would use shrimps(?) in developing nano medicine to reach the inner ear.
Link to the article; https://geminiresearchnews.com/2011/06/gene-therapy-for-ears/
In short, it says that scientists have been using shrimp shells to develop nano particles in order to deliver medicine into the inner ear. From the shrimp shells they are able to make chitosan which in turn makes up the nano particles. These particles have shown to be very good candidates to carry i.e. gene medicine. In this specific trial, they used fluorescent particles that started to emit light once they reached the desired cells, to confirm the delivery of the "drug".
The future is now!
Is this your personal subjective opinion, or are you trying to quote a researcher from the company?Nano technology
Delivery of small molecular drugs like steroid or antioxidant, is likely to be commercialized within 10 years.
However, it is difficult to predict the timing of delivery of genes or a growth factor. It may take decades
Is this your personal subjective opinion, or are you trying to quote a researcher from the company?
If so, then this is one of the most sad news in the world.
I wrote to the company in the summer, and they answered that they are still in many years from the real release of treatment to the market.
But I believe and hope for breakthroughs ahead of the plan, which are always in science.
Of course, if more finances were allocated, all this would move faster.
We all dream in dreams and in reality about the day when we can hear the whole pure range without any interference and tinnitus. May it be so!
I still have not dealt with some issues, and Frequency Therapeutics have become very closed lately and do not respond to letters / Why in the annotation is indicated only noise-induced hearing loss.
Directly from Dong-Kee Kim
Dear Larsen,
Thank you for your interest in my paper.
I think the delivery of small molecular drugs like steroid or antioxidant, is likely to be commercialized within 10 years.
However, it is difficult to predict the timing of delivery of genes or a growth factor. It may take decades
Sincerely
Dong-Kee Kim
https://www.hindawi.com/journals/bmri/2017/3098230/
We don't have the detailed result of the trial yet, just a statement from frequency tx saying that it has been successfulI thought the first tests were succesful, did they (are they able to) measure how far the medicine travel in the cochlea?
I think this is likely the case with any therapy that relies on delivery of a drug to the inner ear. Not sure if it is worse for gene therapy vs. Frequency's small molecules.Will not FT have to deal with the same problem?
I don't see this as relevant to the discussion, and I think 'decades' is way to long for gene therapy in particular (though I would note that he does say 'it may...")Directly from Dong-Kee Kim
That was not part of the trial. They were measuring the concentration in the fluid in the inner ear. The presumption (hope?) is that it will 'bathe' the entire inner ear. My guess is the fact that they are calling it a 'small molecule' means there is a higher likelihood of this than in say gene therapy.I thought the first tests were succesful, did they (are they able to) measure how far the medicine travel in the cochlea?
We've seen nothing at all in living mice/monkeys/humans. There is information in the Mclean et al paper on how long treatments took in their experiments. It was days to a couple of weeks and is obviously not practical in humans. As noted below, I have summarized this earlier in this thread.I've not seen where frequency gives a time frame for it's treatment.
Agreed. Assuming they followed the protocol, then we won't know anything about what is and isn't reached in the cochlea. The only way to know would be to dissect, and that would not be a good thing for the participants!We don't have the detailed result of the trial yet, just a statement from frequency tx saying that it has been successful
I've written at length about this elsewhere in this thread - I think May 2017 or so - so I am not going to repeat myself here at any length. In the published paper, nothing has been regrown in living mice/primates. Presumably they have done this by now, and I am hoping this will be in the next paper. (If they haven't done it yet, it seems extraordinarily unlikely that a trial would begin without some evidence of that.)Has Frequency-tx regrown hair cells in living mice/primates or just tissue?
Wow, with the number of new posts, I figured there was some new news....
I think this is likely the case with any therapy that relies on delivery of a drug to the inner ear. Not sure if it is worse for gene therapy vs. Frequency's small molecules.
I don't see this as relevant to the discussion, and I think 'decades' is way to long for gene therapy in particular (though I would note that he does say 'it may...")
That was not part of the trial. They were measuring the concentration in the fluid in the inner ear. The presumption (hope?) is that it will 'bathe' the entire inner ear. My guess is the fact that they are calling it a 'small molecule' means there is a higher likelihood of this than in say gene therapy.
We've seen nothing at all in living mice/monkeys/humans. There is information in the Mclean et al paper on how long treatments took in their experiments. It was days to a couple of weeks and is obviously not practical in humans. As noted below, I have summarized this earlier in this thread.
Agreed. Assuming they followed the protocol, then we won't know anything about what is and isn't reached in the cochlea. The only way to know would be to dissect, and that would not be a good thing for the participants!
I've written at length about this elsewhere in this thread - I think May 2017 or so - so I am not going to repeat myself here at any length. In the published paper, nothing has been regrown in living mice/primates. Presumably they have done this by now, and I am hoping this will be in the next paper. (If they haven't done it yet, it seems extraordinarily unlikely that a trial would begin without some evidence of that.)
Not 2,000, but 2,000 fold.Wasn't frequency Therapeutics the company that can create hearing cells in the lab and test their own concoctions on it. I think they grew like 2,000 cells from just one test.
http://www.frequencytx.com/news-events/pr-02-21-2017.phpWith the combination of a GSK3 inhibitor to activate the Wnt signaling pathway and a histone deacetylase (HDAC) inhibitor to activate gene transcription, the research team achieved >2000-fold expansion of cochlear supporting cells compared to previous approaches.
I'd be happy with 2,000 additional hearing cells, especially in my T frequency range.Not 2,000, but 2,000 fold.